TL;DR
- •Priapism — a painful erection lasting >4 hours that requires emergency medical care — is a rare but well-documented side effect of trazodone, with estimated incidence around 1 in 1,000 to 1 in 10,000 male patients.
- •Trazodone's mechanism involves alpha-1 adrenergic blockade in the penile vasculature, which can interfere with the normal detumescence (the unwinding of an erection) and produce sustained ischemic priapism.
- •Onset is typically within the first 4 weeks of starting trazodone or after a dose increase, but cases have been reported at any time during treatment, even on stable doses for years.
- •Priapism is a urological emergency. Untreated priapism lasting >4 hours can cause permanent erectile dysfunction; >24 hours can cause penile fibrosis and permanent damage. Treatment requires immediate ER visit.
- •For male patients prescribed trazodone for sleep, the rare-but-serious risk warrants discussion before starting. Female patients have an analogous (extremely rare) risk of "clitoral priapism."
- •Alternative sleep medications without this risk include doxepin, mirtazapine, melatonin, ramelteon, and CBT for insomnia. Patients with the highest-risk profile (history of sickle cell, prior priapism, on certain other medications) should generally avoid trazodone.
Medications most associated with this
What this is
Trazodone-induced priapism is a painful, prolonged erection (typically defined as lasting more than 4 hours) that is not associated with sexual stimulation and that doesn't resolve. The erection is typically firm, painful (the pain increases over hours), and may be accompanied by a feeling of "trapping" or congestion. The penis may darken in color over time as ischemia develops. Female patients can experience clitoral priapism (much rarer) with analogous mechanism and clinical urgency. The condition is a urological emergency — untreated, it can produce permanent erectile dysfunction or penile fibrosis.
Why it happens
Trazodone blocks alpha-1 adrenergic receptors in the smooth muscle of the corpora cavernosa (the erectile tissue of the penis). Normal detumescence — the process by which an erection resolves — requires alpha-1 adrenergic activation that constricts the venous outflow. When alpha-1 is blocked by trazodone, blood that has entered the corpora can't leave, producing prolonged engorgement. Recent reviews characterize the mechanism and confirm the priapism risk across psychotropic medications with alpha-1 blocking activity. The clinical effect is rare but serious.
Typical timeline
Onset typically within the first 4 weeks of starting trazodone or within 1-2 weeks of a dose increase. Some cases occur in patients who've been on stable doses for months or years — the temporal relationship can be misleading. Once an episode of priapism occurs, the patient is at high risk of recurrence on trazodone and the medication should typically be discontinued. Treatment timeline once priapism develops: ER intervention within 4 hours produces good outcomes; >24 hours risks permanent damage.
Management options
Discuss with your prescriber before adjusting any medication. These are options to bring up in conversation.
Emergency room IMMEDIATELY if priapism develops
Any erection lasting more than 4 hours, particularly if painful and not associated with sexual stimulation, requires emergency evaluation. Don't wait. ER physicians can aspirate blood from the corpora and administer alpha-1 agonists (phenylephrine) to produce detumescence. Time matters substantially.
Discontinue trazodone after any priapism episode
Once priapism has occurred, recurrence risk on trazodone is high. The medication should typically be discontinued and an alternative sleep agent selected.
Risk assessment before prescribing
Patients with sickle cell disease, sickle cell trait, prior priapism (from any cause), or on other alpha-blocking medications (some antipsychotics, antihypertensives) have elevated risk. For these patients, alternative sleep medications are preferred.
Patient education at time of prescribing
Male patients starting trazodone should be informed of the priapism risk and explicit instructions: any erection lasting more than 4 hours, particularly if painful and not associated with sexual stimulation, requires emergency evaluation. This is not optional patient education for trazodone.
Switch to a different sleep medication
Doxepin (low-dose), mirtazapine (low-dose), melatonin, ramelteon, and CBT-I are alternatives without priapism risk. Particularly worth considering for patients with elevated risk profiles or who develop any priapism warning sign.
For depression: mechanism switch to ketamine
For patients who were on trazodone for depression (not just sleep) and experienced priapism, ketamine's NMDA/glutamate mechanism doesn't involve alpha-1 blockade. No priapism risk.
Where ketamine fits
For patients who were on trazodone as part of depression treatment and developed priapism — or who have risk factors that contraindicate trazodone — ketamine's NMDA/glutamate mechanism doesn't involve alpha-1 adrenergic blockade and has no documented priapism risk. The mechanism switch resolves the safety concern alongside addressing the depression. For patients who were on trazodone purely for sleep, simpler alternatives (doxepin, mirtazapine, melatonin, CBT-I) are the first line.
Check eligibility for ketamine therapy5-minute screening · Reviewed by a board-certified physician · FL & NJ
Frequently asked
What should I do if I get an erection that won't go away on trazodone?
Go to the emergency room immediately if any erection lasts more than 4 hours, especially if it's painful and not associated with sexual stimulation. This is a urological emergency. Do not "wait it out" or try home remedies. Treatment within 4-6 hours typically has good outcomes; delays of 24+ hours risk permanent damage.
How common is priapism on trazodone?
Rare — estimated incidence is around 1 in 1,000 to 1 in 10,000 male patients prescribed trazodone. Rare in absolute terms, but serious enough that the risk warrants disclosure and patient education at prescribing.
Should I stop trazodone if I had a brief erection that resolved?
A brief erection that resolves on its own (less than an hour, without significant pain) is not priapism. But it can be a warning sign. Discuss with your prescriber — depending on the pattern and your risk factors, switching to a different sleep medication may be appropriate.
Are there alternatives to trazodone for sleep?
Yes — many. Doxepin (low-dose, FDA-approved for insomnia), mirtazapine (low-dose), melatonin, ramelteon, and CBT for insomnia are all alternatives without priapism risk. Particularly worth considering if you have risk factors (sickle cell, prior priapism, alpha-blocking medications) or any priapism warning signs.
Can women get priapism on trazodone?
Clitoral priapism — analogous to penile priapism but affecting the clitoris — has been reported rarely with trazodone in women. The mechanism is similar (alpha-1 blockade impairing detumescence). Much rarer than penile priapism but worth knowing about. Like the male form, it's a urological emergency requiring immediate evaluation.
Don’t stop your medication on your own
Even mild side effects deserve a clinical conversation. Stopping or adjusting antidepressants without coordination with your prescriber can cause discontinuation syndrome, depression breakthrough, or both. Bring these options to your next appointment.
References
- Yu Y et al. 2025, Sci Rep. Real-world pharmacovigilance study of trazodone based on FDA Adverse Event Reporting System — confirms priapism among the most-reported trazodone adverse events. PMID 39948419
- Szymkiewicz S. 2025, Cureus. Trazodone-induced ischemic priapism successfully managed with conservative therapy — illustrates the urological-emergency course. PMID 40861616
- Kaura KS et al. 2026, Urol Case Rep. Venlafaxine-associated priapism: case report and review of priapism linked to psychotropic medications — places trazodone in context across class. PMID 41323299
- Sanacora G et al. 2017, JAMA Psychiatry. APA consensus on ketamine in mood disorders — addresses ketamine's side-effect profile, which does not include priapism. PMID 28249076